Quest Diagnostics (DGX) Tops Q1 EPS by 4c

Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.40, $0.04 better than the analyst estimate of $1.36. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.87 billion.

• Outlook for full-year 2019 remains unchanged

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Traws Pharma (TRAW) Tops Q2 EPS by 27c
• Paramount Global (PARA) Tops Q2 EPS by 480c